NEW YORK (GenomeWeb) – Anthem will cover Exact Sciences' colorectal screening test as a medically necessary procedure under certain conditions, the insurer said in a policy statement on Thursday. 

In its updated policy Anthem said that it will cover the Cologuard test as a medically necessary test once every three years "as a screening technique for individuals in whom colon cancer preventive screening is indicated." For other circumstances, the test is considered investigational and not medically necessary and will not be covered by Anthem.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.